相关实验视频

Updated: Jun 21, 2025

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

TimiGP-Response:与免疫疗法反应相关的泛癌免疫景观

Chenyang Li^1,2, Wei Hong³, Alexandre Reuben^2,4

¹Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

bioRxiv : the preprint server for biology

|July 9, 2024

概括

一个新的计算框架,TimiGP-Response,分析瘤免疫微环境 (TIME) 来预测免疫疗法反应. 它识别了像CD8+ T细胞这样的关键免疫细胞,为各种癌症的治疗疗效提供了洞察力.

科学领域:

免疫学免疫学免疫学
计算生物学计算生物学
在瘤学瘤学.

背景情况:

瘤免疫微环境 (TIME) 极大地影响免疫疗法反应,但其复杂性阻碍了预测.
了解 TIME 内的免疫细胞相互作用对于优化癌症治疗策略至关重要.

研究的目的:

开发和验证TimiGP-Response,这是一个用于分析TIME和预测免疫治疗反应的计算框架.
为了确定特定的免疫细胞群和与泛癌队列治疗疗效相关的相互作用.

主要方法:

利用单细胞和批量转录基因数据与患者反应信息.
构建细胞与细胞相互作用网络,以识别响应者和不响应者的免疫特征.
在三阴性乳腺癌中使用成像质细胞计验证了框架,并在七种癌症类型中分析了3410名患者.

主要成果:

鉴定了CD8+ GZMB+ T细胞及其与调节性T细胞的相互作用,作为三阴性乳腺癌的潜在生物标志物.
揭示了泛癌关联:CD8 T细胞和CD4记忆T细胞与响应者相关,而M2巨细胞和巨细胞与非响应者相关.
突出显示 CD8+ 和 CD4+ GZMK+ 效应器记忆T细胞,因为它们对免疫疗法反应至关重要,以及 IL-17 产生CD8+ T细胞而没有反应.

结论:

TimiGP-Response提供了一种强大的计算方法来剖析TIME及其与免疫治疗结果的关联.
该研究提供了关于免疫细胞动态及其对不同癌症类型治疗疗效的影响的宝贵见解.
确定了关键的免疫细胞亚型和相互作用,可以告知患者分层和免疫疗法的治疗发展.

关键词:

癌症免疫疗法癌症免疫疗法多个omics的多个omics.泛癌分析泛癌分析瘤的免疫微环境

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...